143 related articles for article (PubMed ID: 23833272)
1. Elevated 18F-FDG levels in blood and organs after angiotensin II receptor blocker administration: experiment in mice administered telmisartan.
Zhao Y; Zhao S; Kuge Y; Tamaki N
J Nucl Med; 2013 Aug; 54(8):1384-8. PubMed ID: 23833272
[TBL] [Abstract][Full Text] [Related]
2. DPP-4 inhibition on top of angiotensin receptor blockade offers a new therapeutic approach for diabetic nephropathy.
Alter ML; Ott IM; von Websky K; Tsuprykov O; Sharkovska Y; Krause-Relle K; Raila J; Henze A; Klein T; Hocher B
Kidney Blood Press Res; 2012; 36(1):119-30. PubMed ID: 23171828
[TBL] [Abstract][Full Text] [Related]
3. Prolonged high-fat feeding enhances aortic 18F-FDG and 99mTc-annexin A5 uptake in apolipoprotein E-deficient and wild-type C57BL/6J mice.
Zhao Y; Kuge Y; Zhao S; Strauss HW; Blankenberg FG; Tamaki N
J Nucl Med; 2008 Oct; 49(10):1707-14. PubMed ID: 18794270
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of telmisartan against cadmium-induced nephrotoxicity in mice.
Fouad AA; Jresat I
Life Sci; 2011 Jul; 89(1-2):29-35. PubMed ID: 21620867
[TBL] [Abstract][Full Text] [Related]
5. Long-term renoprotective effects of standard versus high doses of telmisartan in hypertensive nondiabetic nephropathies.
Aranda P; Segura J; Ruilope LM; Aranda FJ; Frutos MA; López V; López de Novales E
Am J Kidney Dis; 2005 Dec; 46(6):1074-9. PubMed ID: 16310573
[TBL] [Abstract][Full Text] [Related]
6. Telmisartan prevents the progression of renal injury in daunorubicin rats with the alteration of angiotensin II and endothelin-1 receptor expression associated with its PPAR-γ agonist actions.
Arozal W; Watanabe K; Veeraveedu PT; Ma M; Thandavarayan RA; Sukumaran V; Suzuki K; Kodama M; Aizawa Y
Toxicology; 2011 Jan; 279(1-3):91-9. PubMed ID: 20888384
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure-lowering and antiproteinuric effect of switching from high-dose angiotensin receptor blockers to normal-dose telmisartan and low-dose hydrochlorothiazide in hypertensive patients with chronic kidney disease.
Abe M; Okada K; Maruyama T; Matsumoto S; Matsumoto K
Int J Clin Pharmacol Ther; 2010 Mar; 48(3):206-13. PubMed ID: 20197015
[TBL] [Abstract][Full Text] [Related]
8. Effects of stimulation of soluble guanylate cyclase on diabetic nephropathy in diabetic eNOS knockout mice on top of angiotensin II receptor blockade.
Ott IM; Alter ML; von Websky K; Kretschmer A; Tsuprykov O; Sharkovska Y; Krause-Relle K; Raila J; Henze A; Stasch JP; Hocher B
PLoS One; 2012; 7(8):e42623. PubMed ID: 22900035
[TBL] [Abstract][Full Text] [Related]
9. The angiotensin receptor blocker, telmisartan, reduces and stabilizes atherosclerosis in ApoE and AT1aR double deficient mice.
Fukuda D; Enomoto S; Hirata Y; Nagai R; Sata M
Biomed Pharmacother; 2010 Dec; 64(10):712-7. PubMed ID: 20970951
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine characterization and anorexigenic effects of telmisartan in diet- and glitazone-induced weight gain.
Aubert G; Burnier M; Dulloo A; Perregaux C; Mazzolai L; Pralong F; Zanchi A
Metabolism; 2010 Jan; 59(1):25-32. PubMed ID: 19793594
[TBL] [Abstract][Full Text] [Related]
11. Effects of telmisartan, hydrochlorothiazide and their combination on blood pressure and renal excretory parameters in spontaneously hypertensive rats.
Wienen W; Schierok HJ
J Renin Angiotensin Aldosterone Syst; 2001 Jun; 2(2):123-8. PubMed ID: 11881111
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of apoptosis by telmisartan in atherosclerotic plaques of apolipoprotein E-/- mice: evaluation using technetium 99m-annexin A5.
Zhao Y; Zhao S; Kuge Y; Strauss HW; Blankenberg FG; Tamaki N
Mol Imaging; 2013; 12(5):300-9. PubMed ID: 23763985
[TBL] [Abstract][Full Text] [Related]
13. Effects of telmisartan and linagliptin when used in combination on blood pressure and oxidative stress in rats with 2-kidney-1-clip hypertension.
Chaykovska L; Alter ML; von Websky K; Hohmann M; Tsuprykov O; Reichetzeder C; Kutil B; Kraft R; Klein T; Hocher B
J Hypertens; 2013 Nov; 31(11):2290-8; discussion 2299. PubMed ID: 24077249
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II receptor blockers differentially affect CYP11B2 expression in human adrenal H295R cells.
Matsuda K; Uruno A; Kogure N; Sugawara K; Shimada H; Nezu M; Saito-Ito T; Iki Y; Kudo M; Shimizu K; Sato I; Yoshikawa T; Satoh F; Ito R; Yokoyama A; Rainey WE; Saito-Hakoda A; Ito S; Sugawara A
Mol Cell Endocrinol; 2014 Mar; 383(1-2):60-8. PubMed ID: 24333837
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the safety and efficacy of telmisartan and enalapril, with the potential addition of frusemide, in moderate-renal failure patients with mild-to-moderate hypertension.
Hannedouche T; Chanard J; Baumelou B;
J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):246-54. PubMed ID: 11881131
[TBL] [Abstract][Full Text] [Related]
16. Renal and vascular protective effects of telmisartan in patients with essential hypertension.
Morimoto S; Yano Y; Maki K; Sawada K
Hypertens Res; 2006 Aug; 29(8):567-72. PubMed ID: 17137211
[TBL] [Abstract][Full Text] [Related]
17. Receptor-independent intracellular radical scavenging activity of an angiotensin II receptor blocker.
Shao J; Nangaku M; Inagi R; Kato H; Miyata T; Matsusaka T; Noiri E; Fujita T
J Hypertens; 2007 Aug; 25(8):1643-9. PubMed ID: 17620961
[TBL] [Abstract][Full Text] [Related]
18. The protective role of telmisartan against nephrotoxicity induced by X-ray contrast media in rat model.
Duan SB; Wang YH; Liu FY; Xu XQ; Wang P; Zou Q; Peng YM
Acta Radiol; 2009 Sep; 50(7):754-9. PubMed ID: 19452295
[TBL] [Abstract][Full Text] [Related]
19. Telmisartan, a dual ARB/partial PPAR-γ agonist, protects myocardium from ischaemic reperfusion injury in experimental diabetes.
Goyal SN; Bharti S; Bhatia J; Nag TC; Ray R; Arya DS
Diabetes Obes Metab; 2011 Jun; 13(6):533-41. PubMed ID: 21320264
[TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin system inhibitors suppress azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice.
Kubota M; Shimizu M; Sakai H; Yasuda Y; Ohno T; Kochi T; Tsurumi H; Tanaka T; Moriwaki H
Biochem Biophys Res Commun; 2011 Jun; 410(1):108-13. PubMed ID: 21640075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
